• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Home | Biochemicals | Cancer Biology | Anticancer | Tyrosine Kinase Inhibitors | FLT

FLT

Product ID
Name
Description
Purity
  • B3472

    4,4′-(1,1′-Biphenyl-4,4′-diyldioxy)dianiline

    Potential VEGFR2, Met, RET, Axl, Ron, PDGFR, FG...

    ≥98%
  • A1616

    AEE-788

    Inhibitor of EGFR, HER2, VEGFR2, and FLT3.

    ≥98%
  • B4976

    BMS-794833

    MET, VEGFR2, Ron, Axl, FLT3 inhibitor.

    ≥98%
  • D0808

    DCC-2036

    Abl inhibitor.

    ≥98%
  • P4008

    PKC412

    Staurosporine derivative; PKC and FLT3 inhibito...

    ≥98%
  • Q8139

    Quizartinib

    FLT3, c-Kit, PDGFR inhibitor.

    ≥98%
  • S8253

    Sunitinib Malate

    Indoline; PDGFR, VEGFR, c-KIT, FLT3, mTORC1 inh...

    ≥98%
  • T0152

    Tandutinib

    FLT3, PDGFR, c-Kit inhibitor.

    ≥98%
  • T5996

    Tozasertib

    AurK, FLT3, Abl inhibitor.

    ≥98%
  • V024761

    Vatalanib

    Inhibitor of VEGFR1/2/3.

    ≥98%
  • V9201

    VX-11e

    ERK2 inhibitor, potential AurKA, GSK3, CDK2, FL...

    ≥98%

Showing all 11 results

sidebar

Store Sidebar

Product Categories

  • Biochemicals (3054)
    • Cancer Biology (1434)
      • Anti-angiogenic (184)
      • Anti-metastatic (85)
      • Anticancer (1183)
        • Anti-mitotics (64)
        • Compounds targeting DNA synthesis and repair (103)
        • DNA Crosslinking and Alkylating Agents (31)
        • Epigenetic Modifiers (52)
        • Hormone Receptor Modulators (37)
        • Inhibitors of other enzymes (80)
        • Nucleoside and Nucleotide Analogs (26)
        • Serine/Threonine Kinase Inhibitors (218)
        • Transcription Factor Modifiers (99)
        • Tyrosine Kinase Inhibitors (145)
          • Abl (15)
          • ALK (19)
          • Axl (5)
          • BTK (4)
          • c-kit (15)
          • c-met (12)
          • EGFR (35)
          • ephR (2)
          • FAK (5)
          • FGFR (9)
          • FLT (11)
          • FYN (2)
          • IGF-1R (8)
          • JAK (20)
          • LCK (3)
          • PDGFR (25)
          • RET (10)
          • Ron (5)
          • ROS1 (5)
          • src (12)
          • TIE (4)
          • TRK (3)
          • VEGFR (26)
      • Antioxidant (362)
      • Carcinogens and Mutagens (39)
      • Chemopreventive (161)
    • Cardiovascular (464)
    • Endocrine Signaling and Immunology (1065)
    • Metabolic and GI Pathology (374)
    • Microbiology (667)
    • Natural Products (725)
    • Neuroscience (793)
    • Peptides (575)
    • Pharmaceutical Impurities and Derivatives (62)
    • Stem Cell Modulators (21)
  • New Products (119)
  • Other Products (66)
  • Uncategorized (10)

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2023 LKT Laboratories, All Rights Reserved - Products for research use only